1. Treatment for metastatic malignant melanoma: old drugs and new strategies;Mouawad;Crit Rev Oncol Hematol,2009
2. Vital signs: melanoma incidence and mortality trends and projections – United States, 1982–2030;Guy;MMWR Morb Mortal Wkly Rep,2015
3. Preclinical studies to predict the disposition of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand in humans: characterization of in vivo efficacy, pharmacokinetics, and safety;Kelley;J Pharmacol Exp Ther,2001
4. Safety and antitumor activity of recombinant soluble Apo2 ligand;Ashkenazi;J Clin Invest,1999
5. Recombinant human tumor necrosis factor-related apoptosis-inducing ligand selectively induces apoptosis in malignant melanoma;Turner;Int J Cancer Oncol,2017